Infinity Pharmaceuticals

Listing Websites about Infinity Pharmaceuticals

Filter Type:

INFI Stock Price Infinity Pharmaceuticals Inc. Stock

(8 days ago) Infinity Pharmaceuticals stock valuation range cut to $1.25-$1.50 from $17-$20 at Wells Fargo. Jun. 15, 2016 at 7:57 a.m. ET by Tomi Kilgore.

Marketwatch.com

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals - IPI

(5 days ago) Infinity Reports Clinical and Translational Data from Expansion Cohorts of MARIO‑1 Phase 1b Study of IPI-549 in Combination with Opdivo® (nivolumab) at SITC's 33rd …

Ipi.com

Category:  Health Detail Drugs


Infinity Pharmaceuticals, Inc. (INFI) Stock Price, News

(6 days ago) Find the latest Infinity Pharmaceuticals, Inc. (INFI) stock quote, history, news and other vital information to help you with your stock trading and investing.

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Should Value Hunters Buy Infinity Pharmaceuticals Inc

(Just Now) Infinity Pharmaceuticals Inc. (NASDAQ:INFI) price closed lower on Friday, October 22, dropping -2.26% below its previous close. A look at the daily price movement shows that the last close reads $2.65, with intraday deals fluctuated between $2.51 and $2.64. The company’s 5Y …

Stocksregister.com

Category:  Pharmaceutical Detail Drugs


INFI Stock Forecast, Price & News (Infinity Pharmaceuticals)

(6 days ago) Infinity Pharmaceuticals' stock was trading at $1.01 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, INFI stock has increased by 161.4% and is now trading at $2.64. View which stocks have been most impacted by COVID-19.

Marketbeat.com

Category:  Pharmaceutical,  Health Detail Drugs


Infinity Pharmaceuticals Inc. (NASDAQ: INFI) Surprised

(6 days ago) In the last trading session, 1.57 million Infinity Pharmaceuticals Inc. (NASDAQ:INFI) shares changed hands as the company’s beta touched 2.17. With the company’s per share price at $3.23 changed hands at -$0.13 or -3.87% during last session, the market valuation stood at …

Marketingsentinel.com

Category:  Pharmaceutical Detail Drugs


Why Infinity Pharmaceuticals Inc. Is Being Obliterated

(5 days ago) Infinity Pharmaceuticals was a risky investment before this announcement was made, and there are now serious questions about its long-term …

Fool.com

Category:  Pharmaceutical Detail Drugs


Jill Goddard - Consultant Clinical Operations - Consultant

(9 days ago) Infinity Pharmaceuticals Sep 2004 - Sep 2011 7 years 1 month. Director, Clinical Operations EPIX Pharmaceuticals 1999 - 2004 5 years. Cambridge, MA Manager

Linkedin.com

Category:  Pharmaceutical Detail Drugs


Why Infinity Pharmaceuticals Shot Nearly 4% Higher Today

(2 days ago) Infinity Pharmaceuticals (NASDAQ:INFI) got off to a market-beating start this week as its shares zoomed 3.8% higher Monday, on the back of new …

Fool.com

Category:  Pharmaceutical Detail Drugs


Contact Us - Infinity Pharmaceuticals, Inc

(2 days ago) Infinity Pharmaceuticals, Inc. 1100 Massachusetts Ave Cambridge, MA 02138 tel: 617-453-1000 fax: 617-453-1001 Inquiries from the financial community and from the media should be sent to [email protected] For more information about Infinity’s in-licensing priorities, please contact [email protected] For general inquiries, please call our headquarters at 617-453-1000 …

Infi.com

Category:  Pharmaceutical Detail Drugs


Investors/Media Infinity Pharmaceuticals, Inc.

(7 days ago) Infinity Pharmaceuticals, Inc. is an innovative biopharmaceutical company dedicated to discovering, developing and delivering best-in-class medicines to people with difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways.

Investors.infi.com

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals, Inc. Common Stock (INFI) Stock

(Just Now) About Infinity Pharmaceuticals, Inc. 1100 MASSACHUSETTS AVENUE FLOOR 4, CAMBRIDGE, Massachusetts, 2138, United States +1 617 453-1000. Infinity Pharmaceuticals Inc is a clinical-stage

Nasdaq.com

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals - Crunchbase Company Profile

(4 days ago) Founders Eric Lander, Frank Moss, Michael Foely. Operating Status Active. Last Funding Type Post-IPO Equity. Legal Name Infinity Pharmaceuticals, Inc. Stock Symbol NASDAQ:INFI. Company Type For Profit. Contact Email [email protected] Phone Number 617-453-1000. Infinity is a clinical-stage biotechnology company developing eganelisib, a potentially

Crunchbase.com

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals Inc. (INFI) Just Got Our

(1 days ago) Infinity Pharmaceuticals Inc. (NASDAQ:INFI) went down by -9.01% from its latest closing price compared to the recent 1-year high of $5.98. The company’s stock price has collected -7.83% of loss in the last five trading sessions. Press Release …

Newsheater.com

Category:  Pharmaceutical Detail Drugs


INFINITY PHARMACEUTICALS

(7 days ago) Infinity Pharmaceuticals is an international pharmaceutical and biotechnology company producing quality life style enhancement and rejuvenation products. We are one of the few companies that can support our partners with such items as: Certificate of Good Manufacturing Practice (GMP). Certificate of Analysis (COA) with every batch.

Infinity-pharmaceuticals.com

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals Presents Updated Data from Phase

(6 days ago) Infinity Pharmaceuticals Presents Updated Data from Phase 2 MARIO-275 Trial in Urothelial Cancer (UC) and Phase 2 MARIO-3 Trial in Triple Negative Breast Cancer (TNBC) July 27, 2021 at 7:31 AM EDT – MARIO-275 median overall survival data show combination of eganelisib with nivolumab achieves 15.4 months compared to 7.9 months on nivolumab

Investors.infi.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Infinity Pharmaceuticals LinkedIn

(6 days ago) Infinity Pharmaceuticals, Inc., is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic

Linkedin.com

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals Price Target, Predictions

(9 days ago) According to the issued ratings of 9 analysts in the last year, the consensus rating for Infinity Pharmaceuticals stock is Buy based on the current 9 buy ratings for INFI. The average twelve-month price target for Infinity Pharmaceuticals is $9.56 with a high price target of $14.00 and a low price target of $4.00. Learn more.

Marketbeat.com

Category:  Pharmaceutical Detail Drugs


Opportunities - Infinity Pharmaceuticals, Inc - Infinity

(1 days ago) Infinity is proud to be an equal opportunity employer and extends employment to men and women from culturally diverse backgrounds. Current Openings Agency Policy: Any recruiter or agency seeking to work with Infinity Pharmaceuticals (the Company) must initially contact our Human Resources Group and enter into an approved search agreement.

Careers-infi.icims.com

Category:  Pharmaceutical Detail Drugs


Why Is Infinity Pharmaceuticals Inc (NASDAQ: INFI) The

(5 days ago) Infinity Pharmaceuticals is “focused on bringing significantly better treatments to cancer patients” and using data-driven methods to achieve those results. The firm focuses on integrity

Finance.yahoo.com

Category:  Pharmaceutical,  Cancer Detail Drugs


INFI Infinity Pharmaceuticals Inc. Profile MarketWatch

(4 days ago) Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It …

Marketwatch.com

Category:  Pharmaceutical,  Cancer Detail Drugs


INFI - Infinity Pharmaceuticals Inc. • BioPharmCatalyst

(5 days ago) Infinity Pharmaceuticals, Inc. ("Infinity" or the "Company"), is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies.

Biopharmcatalyst.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Infinity Pharmaceuticals « New Drug Approvals

(8 days ago) IPI-926 is currently developed by Infinity Pharmaceuticals, Inc. Malignant activation of the Hedgehog pathway is implicated in multiple cancer settings and Infinity’s development strategy is designed to enable IPI-926 to target a broad range of critical oncology targets – from the tumor cell to the cancer microenvironment.

Newdrugapprovals.org

Category:  Pharmaceutical,  Cancer Detail Drugs


Infinity Pharmaceuticals Announces Royalty Monetization of

(3 days ago) Under Infinity's license agreement with Intellikine, LLC, a subsidiary of Takeda Pharmaceuticals Company Limited, Infinity and Takeda would share equally in …

Prnewswire.com

Category:  Pharmaceutical Detail Drugs


INFI News Today (Infinity Pharmaceuticals) MarketBeat

(1 days ago) INFI Stock: Why Infinity Pharmaceuticals Is Soaring After Tuesday’s Plunge investorplace.com - July 28 at 1:16 PM: BRIEF-Infinity Pharmaceuticals Reports Q2 Loss Per Share Of $0.13 msn.com - July 27 at 6:53 PM: Infinity Pharmaceuticals Down 29% After Clinical Trial Update, 2Q Results marketwatch.com - July 27 at 6:53 PM

Marketbeat.com

Category:  Pharmaceutical,  Lung Detail Drugs


Infinity Pharmaceuticals Reports Full Year 2020 Financial

(9 days ago) Infinity Pharmaceuticals, Inc. (“Infinity” or the “Company”), is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies.

Investors.infi.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Infinity Pharmaceuticals Inc. (NASDAQ:INFI) jumps 18.10%

(Just Now) Infinity Pharmaceuticals Inc. (INFI) estimates and forecasts. Statistics highlight that Infinity Pharmaceuticals Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -14.24% of value to its shares in past 6 months, showing an annual growth rate of 19.12% while that of industry is 17.40.

Marketingsentinel.com

Category:  Pharmaceutical Detail Drugs


Trial in Progress: A Phase 2, Multicenter, Single-Arm

(8 days ago) BGB-3111-215 STUDY STATUS • This study opened to accrual in October 2019 and is recruiting patients from 22 sites in the United States WA OR CA NV ID MT WY UT AZ CO NM TX AK HI OK KS NE SD ND MN IA MO AR LA MS AL TN KY IL WI MI IN OH PA WV

Beigenemedical.com

Category:  Health Detail Drugs


Infinity Pharmaceuticals, Inc. (INFI) Latest Stock News

(2 days ago) Why Infinity Pharmaceuticals Blasted 38% Higher Today. Clinical-stage biotech Infinity Pharmaceuticals (NASDAQ: INFI) had a big and bright Monday, with …

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals Reports Inducement Grants to

(6 days ago) CAMBRIDGE, Mass., August 03, 2021--Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) ("Infinity" or the "Company"), a clinical-stage biotechnology company developing eganelisib (IPI-549), a

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


INFI - Infinity Pharmaceuticals Inc Stock quote - CNNMoney.com

(8 days ago) Find real-time INFI - Infinity Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.

Money.cnn.com

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals Stock Forecast: up to 2.877 USD

(3 days ago) Infinity Pharmaceuticals Inc. () Stock Market info Recommendations: Buy or sell Infinity Pharmaceuticals stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Infinity Pharmaceuticals share forecasts, stock quote and buy / sell signals below.According to present data Infinity Pharmaceuticals's INFI shares and potentially its market environment have …

Walletinvestor.com

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals Inc. (NASDAQ: INFI) – Analyst

(4 days ago) Infinity Pharmaceuticals Inc. share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -7.14 percent over the past six months and at a 17.65% annual growth rate that is well below the industry average of 18.10%.

Marketingsentinel.com

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals Inc. (INFI) Down 8.54% in

(6 days ago) Infinity Pharmaceuticals Inc. is lower by Monday morning, with the stock decreasing -8.54% in pre-market trading to 3.32.INFI's short-term technical score of 79 indicates that the stock has traded more bullishly over the last month than 79% of stocks on the market.

Investorsobserver.com

Category:  Pharmaceutical Detail Drugs


INFI: Infinity Pharmaceuticals Inc Stock Price Quote

(9 days ago) Infinity Pharmaceuticals, Inc. researches and develops medicines for the treatment of cancer and related conditions. The Company uses small molecule drug technologies in the development of its

Bloomberg.com

Category:  Pharmaceutical,  Cancer Detail Drugs


Infinity Pharmaceuticals Salaries Glassdoor

(7 days ago) The average Infinity Pharmaceuticals salary ranges from approximately $96,743 per year for a Senior Research Associate to $96,743 per year for a Senior Research Associate. Infinity Pharmaceuticals employees rate the overall compensation and benefits package 4.2/5 stars.

Glassdoor.com

Category:  Pharmaceutical Detail Drugs


Infinity Pharmaceuticals, Inc. - INFI - Stock Price Today

(8 days ago) Infinity Pharmaceuticals, Inc. is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug …

Zacks.com

Category:  Pharmaceutical,  Cancer Detail Drugs


How To Invest In Infinity Pharmaceuticals Inc. (NASDAQ

(4 days ago) Infinity Pharmaceuticals Inc. share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 11.04 percent over the past six months and at a 17.65% annual growth rate that is well below the industry average of 19.00%.

Marketingsentinel.com

Category:  Pharmaceutical Detail Drugs


INFINITY PHARMACEUTICALS, INC. : Stock Market News and

(9 days ago) INFINITY PHARMACEUTICALS, INC. : News, information and stories for INFINITY PHARMACEUTICALS, INC. Nasdaq: INFI Nasdaq

Marketscreener.com

Category:  Pharmaceutical Detail Drugs


Why Infinity Pharmaceuticals Blasted 38% Higher Today

(3 days ago) Infinity Pharmaceuticals is a hot biotech issue at the moment. If eganelisib continues to perform well in clinical trials, there's probably more heat to come. Motley Fool Returns.

Fool.com

Category:  Pharmaceutical Detail Drugs

Filter Type:


Popular Searched

 › Janssen samples for healthcare

 › Walmart pharmacy myrtle beach sc

 › Health canada prescription drugs list

 › 2022 drug list for wellcare

 › Artificial intelligence and medicine

 › Silverscript formulary drug list 2022

 › Medicare diagnosis codes list

 › List of tier 1 drug

 › Medicare tier 1 drugs list

 › Az medical licensing board

Recently Searched

 › Air duct cleaning and sanitation alegria ave drug

 › Nyu internal medicine current residents

 › Artificial intelligence and medicine

 › Aa meetings for drug addiction

 › Diagnosis codes bloodwork medicare

 › Drug treatment los angeles

 › First advantage drug screen locations

 › Wellcare mail in pharmacy

 › Maryland medical assistance provider portal

 › Suffolk tricare prime pharmacy

FAQ about Infinity Pharmaceuticals

What kind of company is Infinity Pharmaceuticals Inc?

Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development.

What are the analyst targets for Infinity Pharmaceuticals?

Their forecasts range from $4.00 to $12.00. On average, they anticipate Infinity Pharmaceuticals' stock price to reach $9.00 in the next year. This suggests a possible upside of 234.6% from the stock's current price. View analysts' price targets for Infinity Pharmaceuticals or view top-rated stocks among Wall Street analysts.

Where is Infinity Pharmaceuticals located in Cambridge MA?

Infinity Pharmaceuticals' mailing address is 1100 MASSACHUSETTS AVENUE FLOOR 4, CAMBRIDGE MA, 02138. The biotechnology company can be reached via phone at 617-453-1000 or via email at [email protected]

When is Infinity Pharmaceuticals first quarter earnings call?

NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 4:30 PM Eastern Time.